Effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) on tissue and urine mercury levels following prolonged methylmercury exposure in rats.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Toxicological Sciences

• Publication date

  2001-06-01

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1093/TOXSCI/61.2.224PMID 11353131
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Determination of methyl mercury in whole blood by ethylation-GC-CVAFS after alkaline digestion-solvent extraction.

  2000cited by this paper
• Neurobehavioral effects from exposure to dental amalgam Hgo: new distinctions between recent exposure and Hg body burden

  1998cited by this paper
• The toxicology of mercury.

  1997cited by this paper
• Utilization of renal slices to evaluate the efficacy of chelating agents for removing mercury from the kidney.

  1997cited by this paper
• Urinary mercury in twelve cases of cutaneous mercurous chloride (calomel) exposure: effect of sodium 2,3-dimercaptopropane-1-sulfonate (DMPS) therapy.

  1997cited by this paper
• Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans. III. Urinary mercury after exposure to mercurous chloride.

  1996cited by this paper
• Sodium 2,3-dimercapto-1-propanesulfonate (DMPS) treatment does not redistribute lead or mercury to the brain of rat.

  1996cited by this paper
• Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans: II. Urinary mercury, porphyrins and neurobehavioral changes of dental workers in Monterrey, Mexico.

  1995cited by this paper
• Mobilization of heavy metals by newer, therapeutically useful chelating agents.

  1995cited by this paper
• Treatment of mercury and lead poisonings with dimercaptosuccinic acid and sodium dimercaptopropanesulfonate. A review.

  1995cited by this paper
• Chemistry of Chelation: Chelating Agent Antagonists for Toxic Metals

  1995influential reference
• Rapid method for the determination of total mercury in urine samples using cold vapour atomic fluorescence spectrometry.

  1994cited by this paper
• Determination and metabolism of dithiol chelating agents. XVI: Pharmacokinetics of 2,3-dimercapto-1-propanesulfonate after intravenous administration to human volunteers.

  1994cited by this paper
• Selective determination of inorganic mercury and methylmercury in tissues by continuous flow and cold vapor atomic absorption spectrometry.

  1993cited by this paper
• Physiological Parameters in Laboratory Animals and Humans

  1993cited by this paper
• Urinary mercury after administration of 2,3‐dimercaptopropane‐1‐sulfonic acid: correlation with dental amalgam score

  1992cited by this paper
• Urinary porphyrin profiles as biomarkers of trace metal exposure and toxicity: studies on urinary porphyrin excretion patterns in rats during prolonged exposure to methyl mercury.

  1991cited by this paper
• Mercury neurotoxicity: mechanisms of blood-brain barrier transport.

  1990cited by this paper
• Accumulation of methylmercury and inorganic mercury in the brain

  1989cited by this paper
• Estimation of mercury burdens in rats by chelation with dimercaptopropane sulfonate.

  1988cited by this paper
• Concepts on metal ion toxicity

  1986cited by this paper
• DMSA and DMPS--water soluble antidotes for heavy metal poisoning.

  1983cited by this paper
• Tests of efficacy of antidotes for removal of methylmercury in human poisoning during the Iraq outbreak.

  1981cited by this paper
• The influence of chelating agents on the distribution and biotransformation of methylmercuric chloride in rats.

  1981cited by this paper
• Handbook on the Toxicology of Metals

  1979cited by this paper
• Renal porphyrinuria during chronic methyl mercury exposure.

  1977cited by this paper
• Renal porphyrinuria during chronic methyl mercury exposure.

  1977cited by this paper
• Ultrastructural and biochemical changes in renal mitochondria during chronic oral methyl mercury exposure: the relationship to renal function.

  1977cited by this paper

• Tamsulosin Attenuates Cardiac Hypertrophy via Integrin‐Linked Kinase: Possible Mechanisms

  2025cites this paper
• Danger in the Classroom: Elemental Mercury Poisoning in Primary School Students

  2025cites this paper
• Sitagliptin Mitigates Diabetic Nephropathy in a Rat Model of Streptozotocin-Induced Type 2 Diabetes: Possible Role of PTP1B/JAK-STAT Pathway

  2023cites this paper
• Porphyrinuria in Autism Spectrum Disorder: A Review.

  2023cites this paper
• α1A Adrenoreceptor blockade attenuates myocardial infarction by modulating the integrin-linked kinase/TGF-β/Smad signaling pathways

  2023cites this paper
• Comparative pharmacokinetics and urinary excretion of arsenic and mercury after oral administration of realgar, cinnabar and AnGongNiuHuang Pill to rats

  2022cites this paper
• Rethinking treatment of mercury poisoning: the roles of selenium, acetylcysteine, and thiol chelators in the treatment of mercury poisoning: a narrative review

  2021cites this paper
• Multimodal Elimination for Intoxication with a Lethal Dose of Organic Mercury

  2019cites this paper
• Mercury leaching from dental amalgam fillings and its association with urinary zinc

  2019cites this paper
• POLYCARBOXYLATED PORPHYRINS AND USE THEREOF IN TREATMENT OF METAL TOXCITIES BACKGROUND OF THE INVENTION

  2017cites this paper
• Healing of Amyotrophic Lateral Sclerosis: A Case Report

  2017cites this paper
• Nano drug delivery systems: a new paradigm for treating metal toxicity

  2016cites this paper
• Chapter 46 – Mercury

  2015cites this paper
• Dimercaptopropane Sulfonate Chelation Affects In Vivo Hg and MeHg Distribution in Tissues and Urine of Prairie Voles (Microtus ochrogaster)

  2015cites this paper
• Genetic Polymorphisms of Catechol-O-Methyltransferase Modify the Neurobehavioral Effects of Mercury in Children

  2014cites this paper
• Current approaches of the management of mercury poisoning: need of the hour

  2014cites this paper
• Genetic polymorphisms affecting susceptibility to mercury neurotoxicity in children: summary findings from the Casa Pia Children's Amalgam clinical trial.

  2014cites this paper
• Toxic Metals: Health Effects, and Therapeutic Measures

  2014cites this paper
• Modification of neurobehavioral effects of mercury by genetic polymorphisms of metallothionein in children.

  2013cites this paper
• Urinary Porphyrins in Autism Spectrum Disorders

  2013cites this paper
• 3.35 – Chelation Therapy

  2013cites this paper
• A simple selective protocol for continuous two-stage fluorescent sensing of both MeHg+ and anti-MeHg+ agents in living cells

  2012cites this paper
• Modification of neurobehavioral effects of mercury by a genetic polymorphism of coproporphyrinogen oxidase in children.

  2012cites this paper
• Role of Calcium and Mitochondria in MeHg-Mediated Cytotoxicity

  2012cites this paper
• Environmental Chemicals and Neurotoxicity Oxidative stress in MeHg-induced neurotoxicity

  2011cites this paper
• Oxidative stress in MeHg-induced neurotoxicity.

  2011cites this paper
• Chemical and radiochemical considerations in radiolabeling with α-emitting radionuclides.

  2011cites this paper
• Toxicity biomarkers in autism spectrum disorder: A blinded study of urinary porphyrins

  2011cites this paper
• Modulation of methylmercury uptake by methionine: prevention of mitochondrial dysfunction in rat liver slices by a mimicry mechanism.

  2011cites this paper
• Urinary Porphyrin Excretion in Neurotypical and Autistic Children

  2010cites this paper
• Structure-activity relationship of flavonoids derived from medicinal plants in preventing methylmercury-induced mitochondrial dysfunction.

  2010cites this paper
• Toxicity biomarkers among US children compared to a similar cohort in France: a blinded study measuring urinary porphyrins

  2010cites this paper
• Increased Urinary Excretion of Carnitine and Acylcarnitine by Mercuric Chloride Is Reversed by 2,3-Dimercapto-1-Propanesulfonic Acid in Rats

  2010cites this paper
• The Association Between Serotonin Transporter Gene Promotor Polymorphism (5-HTTLPR) and Elemental Mercury Exposure on Mood and Behavior in Humans

  2010cites this paper
• Urinary porphyrin excretion in normal children and adolescents.

  2009cites this paper
• Synergistic neurotoxicity induced by methylmercury and quercetin in mice.

  2009cites this paper
• The Association Between Serotonin Transporter Gene Promoter Polymorphism (5-HTTLPR), Self-Reported Symptoms, and Dental Mercury Exposure

  2008cites this paper
• Kawasaki's disease, acrodynia, and mercury.

  2008cites this paper
• EFEITO DO DISSELENETO DE DIFENILA SOBRE A TOXICIDADE INDUZIDA POR CLORETO DE MERCÚRIO EM CAMUNDONGOS

  2008cites this paper
• The Contribution of Dental Amalgam to Urinary Mercury Excretion in Children

  2007cites this paper
• Effects of BSO, GSH, Vit-C and DMPS on the nephrotoxicity of mercury.

  2007cites this paper
• CHAPTER 33 – Mercury

  2007cites this paper
• Mercury distribution and excretion in prairie voles following exposure to methylmercury and chelation treatment

  2007cites this paper
• Effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) on methylmercury-induced locomotor deficits and cerebellar toxicity in mice.

  2007cites this paper
• Effects of BSO, GSH, Vit-C and DMPS on the nephrotoxicity of mercury

  2007cites this paper
• Mercury and Methylmercury Accumulation and Excretion in Prairie Voles (Microtus ochrogaster) Receiving Chronic Doses of Methylmercury

  2007influential citation
• 2,3-Dimercaptopropanol, 2,3-dimercaptopropane-1-sulfonic acid and meso-2,3-dimercaptosuccinic acid increase lead-induced inhibition of delta-aminolevulinate dehydratase in vitro and ex vivo.

  2006cites this paper
• A cascade analysis of the interaction of mercury and coproporphyrinogen oxidase (CPOX) polymorphism on the heme biosynthetic pathway and porphyrin production.

  2006cites this paper
• Chronic low-level mercury exposure, BDNF polymorphism, and associations with cognitive and motor function.

  2005cites this paper
• The association between genetic polymorphisms of coproporphyrinogen oxidase and an atypical porphyrinogenic response to mercury exposure in humans.

  2005cites this paper
• Chronic low-level mercury exposure, BDNF polymorphism, and associations with self-reported symptoms and mood.

  2004cites this paper
• Effects of mercury and selenite on delta-aminolevulinate dehydratase activity and on selected oxidative stress parameters in rats.

  2004cites this paper
• Blood mercury following DMPS administration to subjects with and without dental amalgam.

  2003cites this paper
• Interaction Between Metals and Chelating Agents Affects Glutamate Binding on Brain Synaptic Membranes

  2003cites this paper
• 2,3-Dimercaptopropane-1-sulfonic acid and meso-2,3-dimercaptosuccinic acid increase mercury- and cadmium-induced inhibition of delta-aminolevulinate dehydratase.

  2003cites this paper
• Quantitative evaluation of urinary porphyrins as a measure of kidney mercury content and mercury body burden during prolonged methylmercury exposure in rats.

  2001cites this paper